查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1943683

跳蚤和蜱虫防治产品市场－全球产业规模、份额、趋势、机会及预测（按类型、宠物类型、分销管道、地区和竞争格局划分，2021-2031年）

Flea and Tick Products Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By Pet Type, By Distribution Channel, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

全球跳蚤和蜱虫防治产品市场预计将从 2025 年的 89.7 亿美元成长到 2031 年的 154.7 亿美元，复合年增长率为 9.51%。

这些产品包括各种化学或天然配方，例如口服药物、外用溶液、喷雾剂和项圈，旨在防治和预防伴侣动物的体外寄生虫感染。推动这一增长的关键因素是宠物日益人性化以及公众对寄生虫疾病的认识不断提高，这两点都促使饲主更加重视预防性兽医护理。与产品偏好的变化不同，这些根本驱动因素已经建立起以家庭安全和动物福利为基础的基本需求水准。

市场概览
预测期 2027-2031
市场规模：2025年 89.7亿美元
市场规模：2031年 154.7亿美元
复合年增长率：2026-2031年 9.51%
成长最快的细分市场 猫
最大的市场 北美洲

儘管成长前景乐观，但市场仍面临许多挑战，包括严格的法规环境和仿冒品的氾滥，这些都威胁着消费者的信任和安全标准。然而，在必要的医疗保健支出支撑下，该行业保持着强劲的财务韧性。美国宠物用品协会报告称，到2024年，美国宠物产业在兽医护理和产品销售方面的总支出将达到398亿美元，这充分体现了人们对动物健康的坚定承诺。这项巨额投资表明，宠物饲主将动物保健和保护解决方案视为重中之重，确保了该市场在面临营运挑战的情况下仍能保持活力。

市场驱动因素

宠物人性化和优质化的趋势日益加速，成为市场成长的主要催化剂。饲主越来越将他们的伴侣动物视为家庭成员，并认为它们应该享受一流的医疗保健。这种文化转变促使人们愿意用更优质、更便利的产品来取代基础的功能性治疗，例如偏好极佳的咀嚼片和持久耐用的项圈。根据欧洲宠物用品及配件联合会（FEDIAF）于2024年6月发布的《2024年事实与数据》报告，目前欧洲家庭饲养宠物的数量高达3.52亿隻，这构成了一个庞大的饲主更有可能采取预防性健康策略。因此，製造商正致力于开发便捷的给药方法和综合疗法，以满足这些爱宠物饲主的生活方式和舒适度需求。

此外，气候变迁正成为关键的环境因素，扩大了寄生虫的季节性和地理分布范围，因此需要将策略从季节性防护转向全年通讯协定。全球暖化使得跳蚤和蜱虫能够在以前未受影响的地区生存，并在冬季保持活跃，从而增加了红血病和莱姆病等媒介传播疾病的风险。根据伴侣动物寄生虫委员会 (CAPC) 于 2024 年 4 月发布的《2024 年宠物寄生虫预测》，蜱传疾病和心丝虫病的威胁持续向西北方向蔓延至非流行地区，这更加凸显了持续预防的必要性。这种生物压力确保了领先製药公司稳定的收入。例如，硕腾公司 (Zoetis) 报告称，其伴侣动物产品组合在 2024 年第三季的收入为 24 亿美元，这主要得益于其先进驱虫产品线的持续需求。

市场挑战

严格的法规结构，加上仿冒品的氾滥，构成了复杂的壁垒，严重阻碍了全球跳蚤和蜱虫防治产品市场的成长。政府对化学品功效和安全性的严格监管迫使製造商投入大量时间和资金进行产品检验。这种沉重的合规负担减缓了创新速度，阻碍了企业快速推出对抗新出现的寄生虫抗药性所需的先进配方。因此，高准入门槛限制了市场弹性，并延缓了新产品线的产生收入。根据美国动物健康研究所 (AHI) 2024 年的报告，一种新的伴侣动物用药品要获得完整的核准流程，平均需要 6.5 年的研发时间和 2,250 万美元的投资才能达到联邦标准。

同时，仿冒品的氾滥贬低了合法市场的价值，并威胁到动物福利。这些非法产品外观往往与合法品牌完全相同，却绕过了安全测试，可能导致宠物出现不良反应。此类不安全替代品的氾滥削弱了消费者对整个产业的信任。当宠物饲主对现有治疗方法的安全性缺乏信心时，他们往往会降低预防性治疗的依从性，或犹豫是否购买优质产品，从而导致潜在市场萎缩，并阻碍了市场成长。

市场趋势

电子商务和消费者订阅模式的扩张正在从根本上改变市场动态，将分销管道从传统兽医诊所转移到确保药物持续使用的数位平台。这种通路转变的特点是订阅配送服务的广泛应用，从而确保了持续的收入，并降低了人工采购週期中可能出现的供应缺口风险。大型线上零售商正利用这种持续的消费行为来获取可观的市场份额。例如，Chewy在2024年12月发布的「2024年第三季财报电话会议纪录」中报告称，自动续订客户的销售额达到23亿美元，占总净销售额的80%，这证实了宠物健康领域消费者对自动补货服务的强烈偏好。

此外，多效合一频谱复方製剂的普及标誌着价值策略的趋同，单剂量配方即可同时防治体内外寄生虫，占据了消费者支出的大部分。与需要多次给药的传统治疗方法不同，这些三效合一产品只需一次咀嚼即可提供全面保护，有效替代了跳蚤、蜱虫和心丝虫的单独预防药物，从而推动了财务增长。这种转变正在为拥有已通过核准复方製剂的大型製药公司创造一个收入集中的市场格局。例如，硕腾公司在2024年11月的「2024年第三季」财报电话会议上宣布，其三效合一产品Simparica Trio在美国的销售额增长了29%，达到2.37亿美元，这表明这些多功能解决方案正在迅速获得商业性认可。

目录

第一章概述

第二章调查方法

第三章执行摘要

第四章：客户评价

第五章 全球跳蚤和蜱虫防治产品市场展望

  • 市场规模及预测
    • 按金额
  • 市占率及预测
    • 依类型（口服锭剂、喷雾剂、滴剂、粉末、洗髮精、项圈、咀嚼片、其他）
    • 宠物类型（猫、狗、其他）
    • 按分销管道（线下、线上）
    • 按地区
    • 按公司（2025 年）
  • 市场地图

6. 北美跳蚤和蜱虫防治产品市场展望

  • 市场规模及预测
  • 市占率及预测
  • 北美洲：国家分析
    • 我们
    • 加拿大
    • 墨西哥

7. 欧洲跳蚤和蜱虫防治产品市场展望

  • 市场规模及预测
  • 市占率及预测
  • 欧洲：国家分析
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙

8. 亚太地区跳蚤和蜱虫防治产品市场展望

  • 市场规模及预测
  • 市占率及预测
  • 亚太地区：国家分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲

9. 中东和非洲跳蚤和蜱虫防治产品市场展望

  • 市场规模及预测
  • 市占率及预测
  • 中东和非洲：国家分析
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非

10. 南美洲跳蚤和蜱虫防治产品市场展望

  • 市场规模及预测
  • 市占率及预测
  • 南美洲：国家分析
    • 巴西
    • 哥伦比亚
    • 阿根廷

第十一章 市场动态

  • 司机
  • 任务

第十二章 市场趋势与发展

  • 併购
  • 产品发布
  • 最新进展

13. 全球跳蚤和蜱虫防治产品市场：SWOT 分析

第十四章 波特五力分析

  • 产业竞争
  • 新进入者的可能性
  • 供应商电力
  • 顾客权力
  • 替代品的威胁

第十五章 竞争格局

  • Ceva Animal Health, LLC
  • Elanco Animal Health Incorporated
  • Virbac SA
  • Boehringer Ingelheim International GmbH
  • Eli Lilly and Company
  • PetIQ, LLC
  • The Hartz Mountain Corporation
  • Kittrich Corporation
  • Central Garden & Pet Company
  • Merck & Co., Inc.

第十六章 策略建议

第十七章：关于研究公司及免责声明

简介目录
Product Code: 16027

The Global Flea and Tick Products Market is projected to expand from USD 8.97 Billion in 2025 to USD 15.47 Billion by 2031, reflecting a Compound Annual Growth Rate (CAGR) of 9.51%. These products encompass various chemical or natural formulations, including oral medications, topical solutions, sprays, and collars, intended to eradicate and prevent external parasite infestations on companion animals. The primary forces propelling this growth include the rising trend of pet humanization and increased public awareness concerning parasite-transmitted diseases, both of which urge owners to prioritize preventative veterinary care. Distinct from shifting product preferences, these fundamental drivers establish a baseline level of essential demand rooted in household safety and animal welfare.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 8.97 Billion
Market Size 2031USD 15.47 Billion
CAGR 2026-20319.51%
Fastest Growing SegmentCat
Largest MarketNorth America

Despite positive growth prospects, the market faces significant hurdles, specifically a rigorous regulatory environment and the spread of counterfeit goods which threaten consumer confidence and safety standards. Nevertheless, the sector maintains strong financial resilience driven by essential health expenditures. As evidence of this unwavering commitment to animal health, the American Pet Products Association reported in 2024 that United States pet industry spending specifically for veterinary care and product sales totaled $39.8 billion. This considerable investment underscores the high priority pet owners assign to medical and protective solutions for their animals, ensuring sustained market relevance despite operational challenges.

Market Driver

The escalating trend of pet humanization and premiumization acts as a major catalyst for market growth, as owners increasingly treat companion animals as core family members requiring top-tier healthcare. This cultural evolution fosters a willingness to purchase superior, user-friendly formulations like palatable chews and long-lasting collars, replacing basic functional treatments. According to the 'Facts & Figures 2024' report released by FEDIAF in June 2024, European households currently care for 352 million pets, creating a vast demographic of owners statistically more likely to adopt preventative health strategies. Consequently, manufacturers are focusing on developing convenient application methods and combination therapies that suit the lifestyles and comfort requirements of these dedicated pet parents.

Additionally, climate change acts as a critical environmental driver by extending the seasonality and geographical range of parasites, necessitating a strategic transition from seasonal to year-round protection protocols. Rising global temperatures enable fleas and ticks to survive in previously unaffected regions and remain active during winter, heightening the risk of vector-borne illnesses such as ehrlichiosis and Lyme disease. According to the Companion Animal Parasite Council's '2024 Pet Parasite Forecast' from April 2024, the threat of tick-borne diseases and heartworm has continued to expand northward and westward into non-endemic areas, reinforcing the need for continuous prophylaxis. This biological pressure guarantees consistent revenue for pharmaceutical leaders; for instance, Zoetis reported third-quarter 2024 revenue of $2.4 billion for its companion animal portfolio, largely fueled by sustained demand for its advanced parasiticide lines.

Market Challenge

The combination of a strict regulatory framework and the proliferation of counterfeit items presents a complex barrier that substantially impedes the growth of the global flea and tick products market. Rigid government mandates concerning chemical efficacy and safety compel manufacturers to invest significant time and capital into product validation. This heavy compliance load decelerates innovation, hindering companies from rapidly introducing advanced formulations required to combat emerging parasite resistance. As a result, high entry barriers restrict market agility and delay revenue generation from new lines; according to the Animal Health Institute in 2024, the full approval process for a new companion animal pharmaceutical averaged 6.5 years in development time and $22.5 million in investment to meet federal standards.

Concurrently, the widespread circulation of counterfeit merchandise diminishes legitimate market value and endangers animal welfare. These illicit products, frequently identical in appearance to authentic brands, evade safety testing and can induce adverse reactions in pets. The ubiquity of such dangerous alternatives undermines consumer confidence across the entire category. When pet owners lack trust in the safety of available treatments, they often decrease adherence to preventative regimens or hesitate to buy premium solutions, effectively contracting the total addressable market and stalling financial growth.

Market Trends

The expansion of e-commerce and direct-to-consumer subscription models is fundamentally reshaping market dynamics by moving distribution power from traditional veterinary clinics to digital platforms that ensure medication adherence. This channel shift is characterized by the broad adoption of auto-ship programs, which secure recurring revenue and reduce the risk of coverage gaps associated with manual purchasing cycles. Major online retailers are leveraging this consistent consumer behavior to seize significant market share. For example, Chewy reported in its 'Q3 2024 Earnings Call Transcript' from December 2024 that its Autoship customer sales hit $2.3 billion, accounting for 80% of total net sales, underscoring the strong consumer preference for automated replenishment within the pet health sector.

Furthermore, the proliferation of all-in-one broad-spectrum combination therapeutics signifies a strategic consolidation of value, where single-dose formulations addressing both internal and external parasites are securing the majority of consumer spending. Unlike legacy treatments that require multiple administrations, these triple-action products drive financial growth by providing comprehensive protection in a single chew, effectively replacing separate preventatives for fleas, ticks, and heartworm. This transition creates a concentrated revenue landscape for pharmaceutical leaders possessing approved comprehensive labels. As an illustration of this trend, Zoetis announced in its 'Third Quarter 2024 Financial Results' in November 2024 that revenue for its triple-combination product, Simparica Trio, rose by 29% in the U.S. to $237 million, demonstrating the rapid commercial adoption of these multi-modal solutions.

Key Market Players

  • Ceva Animal Health, LLC
  • Elanco Animal Health Incorporated
  • Virbac S.A.
  • Boehringer Ingelheim International GmbH
  • Eli Lilly and Company
  • PetIQ, LLC
  • The Hartz Mountain Corporation
  • Kittrich Corporation
  • Central Garden & Pet Company
  • Merck & Co., Inc.

Report Scope

In this report, the Global Flea and Tick Products Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Flea and Tick Products Market, By Type

  • Oral Pill
  • Spray
  • Spot On
  • Powder
  • Shampoo
  • Collar
  • Chewable
  • Others

Flea and Tick Products Market, By Pet Type

  • Cat
  • Dog
  • Others

Flea and Tick Products Market, By Distribution Channel

  • Offline
  • Online

Flea and Tick Products Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Flea and Tick Products Market.

Available Customizations:

Global Flea and Tick Products Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Flea and Tick Products Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (Oral Pill, Spray, Spot On, Powder, Shampoo, Collar, Chewable, Others)
    • 5.2.2. By Pet Type (Cat, Dog, Others)
    • 5.2.3. By Distribution Channel (Offline, Online)
    • 5.2.4. By Region
    • 5.2.5. By Company (2025)
  • 5.3. Market Map

6. North America Flea and Tick Products Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Pet Type
    • 6.2.3. By Distribution Channel
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Flea and Tick Products Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By Pet Type
        • 6.3.1.2.3. By Distribution Channel
    • 6.3.2. Canada Flea and Tick Products Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By Pet Type
        • 6.3.2.2.3. By Distribution Channel
    • 6.3.3. Mexico Flea and Tick Products Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By Pet Type
        • 6.3.3.2.3. By Distribution Channel

7. Europe Flea and Tick Products Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Pet Type
    • 7.2.3. By Distribution Channel
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Flea and Tick Products Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Pet Type
        • 7.3.1.2.3. By Distribution Channel
    • 7.3.2. France Flea and Tick Products Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Pet Type
        • 7.3.2.2.3. By Distribution Channel
    • 7.3.3. United Kingdom Flea and Tick Products Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Pet Type
        • 7.3.3.2.3. By Distribution Channel
    • 7.3.4. Italy Flea and Tick Products Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By Pet Type
        • 7.3.4.2.3. By Distribution Channel
    • 7.3.5. Spain Flea and Tick Products Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By Pet Type
        • 7.3.5.2.3. By Distribution Channel

8. Asia Pacific Flea and Tick Products Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Pet Type
    • 8.2.3. By Distribution Channel
    • 8.2.4. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Flea and Tick Products Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Pet Type
        • 8.3.1.2.3. By Distribution Channel
    • 8.3.2. India Flea and Tick Products Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Pet Type
        • 8.3.2.2.3. By Distribution Channel
    • 8.3.3. Japan Flea and Tick Products Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Pet Type
        • 8.3.3.2.3. By Distribution Channel
    • 8.3.4. South Korea Flea and Tick Products Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Pet Type
        • 8.3.4.2.3. By Distribution Channel
    • 8.3.5. Australia Flea and Tick Products Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Pet Type
        • 8.3.5.2.3. By Distribution Channel

9. Middle East & Africa Flea and Tick Products Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Pet Type
    • 9.2.3. By Distribution Channel
    • 9.2.4. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Flea and Tick Products Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Pet Type
        • 9.3.1.2.3. By Distribution Channel
    • 9.3.2. UAE Flea and Tick Products Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Pet Type
        • 9.3.2.2.3. By Distribution Channel
    • 9.3.3. South Africa Flea and Tick Products Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Pet Type
        • 9.3.3.2.3. By Distribution Channel

10. South America Flea and Tick Products Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Pet Type
    • 10.2.3. By Distribution Channel
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Flea and Tick Products Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Pet Type
        • 10.3.1.2.3. By Distribution Channel
    • 10.3.2. Colombia Flea and Tick Products Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Pet Type
        • 10.3.2.2.3. By Distribution Channel
    • 10.3.3. Argentina Flea and Tick Products Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Pet Type
        • 10.3.3.2.3. By Distribution Channel

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Flea and Tick Products Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Ceva Animal Health, LLC
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Elanco Animal Health Incorporated
  • 15.3. Virbac S.A.
  • 15.4. Boehringer Ingelheim International GmbH
  • 15.5. Eli Lilly and Company
  • 15.6. PetIQ, LLC
  • 15.7. The Hartz Mountain Corporation
  • 15.8. Kittrich Corporation
  • 15.9. Central Garden & Pet Company
  • 15.10. Merck & Co., Inc.

16. Strategic Recommendations

17. About Us & Disclaimer